These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 20009002)
1. (18)F-FDG avidity in lymphoma readdressed: a study of 766 patients. Weiler-Sagie M; Bushelev O; Epelbaum R; Dann EJ; Haim N; Avivi I; Ben-Barak A; Ben-Arie Y; Bar-Shalom R; Israel O J Nucl Med; 2010 Jan; 51(1):25-30. PubMed ID: 20009002 [TBL] [Abstract][Full Text] [Related]
2. The usefulness of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) and a comparison of (18)F-FDG-pet with (67)gallium scintigraphy in the evaluation of lymphoma: relation to histologic subtypes based on the World Health Organization classification. Tsukamoto N; Kojima M; Hasegawa M; Oriuchi N; Matsushima T; Yokohama A; Saitoh T; Handa H; Endo K; Murakami H Cancer; 2007 Aug; 110(3):652-9. PubMed ID: 17582800 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of diffusion-weighted MRI for pretherapeutic assessment and staging of lymphoma: results of a prospective study in 140 patients. Mayerhoefer ME; Karanikas G; Kletter K; Prosch H; Kiesewetter B; Skrabs C; Porpaczy E; Weber M; Pinker-Domenig K; Berzaczy D; Hoffmann M; Sillaber C; Jaeger U; Müllauer L; Simonitsch-Klupp I; Dolak W; Gaiger A; Ubl P; Lukas J; Raderer M Clin Cancer Res; 2014 Jun; 20(11):2984-93. PubMed ID: 24696320 [TBL] [Abstract][Full Text] [Related]
4. False-Positive [18F]fluorodeoxyglucose-avid lymph nodes on positron emission tomography-computed tomography after allogeneic but not autologous stem-cell transplantation in patients with lymphoma. Ulaner GA; Lilienstein J; Gönen M; Maragulia J; Moskowitz CH; Zelenetz AD J Clin Oncol; 2014 Jan; 32(1):51-6. PubMed ID: 24248697 [TBL] [Abstract][Full Text] [Related]
5. Standardized uptake value for (18)F-fluorodeoxyglucose is correlated with a high International Prognostic Index and the presence of extranodal involvement in patients with diffuse large B-cell lymphoma. Akkas BE; Vural GU Rev Esp Med Nucl Imagen Mol; 2014; 33(3):148-52. PubMed ID: 24094371 [TBL] [Abstract][Full Text] [Related]
6. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility. Basu S; Li G; Bural G; Alavi A Acta Radiol; 2009 Mar; 50(2):201-4. PubMed ID: 19089692 [TBL] [Abstract][Full Text] [Related]
7. Utility of 18F-FDG PET/CT for staging NK/T-cell lymphomas. Wu HB; Wang QS; Wang MF; Li HS; Zhou WL; Ye XH; Wang QY Nucl Med Commun; 2010 Mar; 31(3):195-200. PubMed ID: 20009963 [TBL] [Abstract][Full Text] [Related]
8. The role of 18F-FDG PET/CT for initial staging of nasal type natural killer/T-cell lymphoma: a comparison with conventional staging methods. Moon SH; Cho SK; Kim WS; Kim SJ; Chan Ahn Y; Choe YS; Lee KH; Kim BT; Choi JY J Nucl Med; 2013 Jul; 54(7):1039-44. PubMed ID: 23658217 [TBL] [Abstract][Full Text] [Related]
9. Comparison of Kaste SC; Snyder SE; Metzger ML; Sandlund JT; Howard SC; Krasin M; Shulkin BL J Nucl Med; 2017 Mar; 58(3):419-424. PubMed ID: 27609791 [TBL] [Abstract][Full Text] [Related]
10. FDG avidity and PET/CT patterns in primary gastric lymphoma. Radan L; Fischer D; Bar-Shalom R; Dann EJ; Epelbaum R; Haim N; Gaitini D; Israel O Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1424-30. PubMed ID: 18418594 [TBL] [Abstract][Full Text] [Related]
11. 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) for staging and follow-up of marginal zone B-cell lymphoma. Hoffmann M; Kletter K; Becherer A; Jäger U; Chott A; Raderer M Oncology; 2003; 64(4):336-40. PubMed ID: 12759529 [TBL] [Abstract][Full Text] [Related]
12. The impact of fluorodeoxyglucose-positron emission tomography in primary staging and patient management in lymphoma patients. Allen-Auerbach M; de Vos S; Czernin J Radiol Clin North Am; 2008 Mar; 46(2):199-211, vii. PubMed ID: 18619376 [TBL] [Abstract][Full Text] [Related]
13. Characterization of T-cell lymphomas by FDG PET/CT. Feeney J; Horwitz S; Gönen M; Schöder H AJR Am J Roentgenol; 2010 Aug; 195(2):333-40. PubMed ID: 20651187 [TBL] [Abstract][Full Text] [Related]
14. 18F-FDG uptake and its clinical relevance in primary gastric lymphoma. Yi JH; Kim SJ; Choi JY; Ko YH; Kim BT; Kim WS Hematol Oncol; 2010 Jun; 28(2):57-61. PubMed ID: 19593742 [TBL] [Abstract][Full Text] [Related]
15. Distinct FDG PET/CT avidity among newly diagnosed intravascular large B-cell lymphoma patients: a descriptive observational study. Zhao D; Zhang Y; Zhu W; Huo L; Zhou D; Wang W; Wei C; Zhang W Ann Hematol; 2024 Feb; 103(2):545-552. PubMed ID: 37932469 [TBL] [Abstract][Full Text] [Related]
16. [18F-FDG uptake of lymphoma lesions of various histological subtypes]. Ma LF; Fan W Ai Zheng; 2009 Apr; 28(4):425-30. PubMed ID: 19622306 [TBL] [Abstract][Full Text] [Related]
17. The role of Wang W; Ni X; Tang T; Wang J; Li Y; Song X Br J Radiol; 2022 Feb; 95(1130):20210635. PubMed ID: 34919440 [TBL] [Abstract][Full Text] [Related]
18. The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas. Schrepfer T; Haerle SK; Strobel K; Schaefer N; Hälg RA; Huber GF Laryngoscope; 2010 May; 120(5):937-44. PubMed ID: 20422687 [TBL] [Abstract][Full Text] [Related]
19. 18F-FDG PET for evaluation of the treatment response in patients with gastrointestinal tract lymphomas. Kumar R; Xiu Y; Potenta S; Mavi A; Zhuang H; Yu JQ; Dhurairaj T; Dadparvar S; Alavi A J Nucl Med; 2004 Nov; 45(11):1796-803. PubMed ID: 15534046 [TBL] [Abstract][Full Text] [Related]
20. 18F-Fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography in mucosa-associated lymphoid tissue lymphoma: variation in 18F-FDG avidity according to site involvement. Park SH; Lee JJ; Kim HO; Lee DY; Suh C; Jung HY; Choi KD; Kim DH; Huh J; Ryu JS Leuk Lymphoma; 2015; 56(12):3288-94. PubMed ID: 25804932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]